Paul Wren is the founder of ESCAPE Bio. ESCAPE Bio has raised $184M in total funding. Latest round: Series C. Based in South San Francisco, California.
Paul Wren, Ph.D., is the Chief Scientific Officer at ESCAPE Bio, a clinical-stage biopharmaceutical company focused on developing targeted therapeutics for genetically-defined neurodegenerative diseases. In this role, he is responsible for leading the company's scientific strategy and advancing experimental medicines for conditions such as lysosomal storage disorders and Parkinson's disease.
Full founder directory · Investor directory · Company funding database · Fundraising library